As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money.
So let's look at two noteworthy recent insider buys.
At SenesTech (SNES), a filing with the SEC revealed that on Tuesday, CEO Kenneth S.
Siegel bought 696,296 shares of SNES, at a cost of $1.35 each, for a total investment of $940,000.
Siegel was up about 3.7% on the buy at the high point of today's trading session, with SNES trading as high as $1.40 at last check today.
SenesTech is trading up about 2.3% on the day Friday.
This purchase marks the first one filed by Siegel in the past twelve months.
And on Thursday, Director Leonard Sank purchased $195,711 worth of Oramed Pharmaceuticals (ORMP), purchasing 54,517 shares at a cost of $3.59 a piece.
Before this latest buy, Sank made one other buy in the past year, purchasing $4,250 shares for a cost of $3.22 each.
Oramed Pharmaceuticals is trading up about 0.6% on the day Friday.
So far Sank is in the green, up about 11.4% on their buy based on today's trading high of $4.00.